Stocks and Investing
Stocks and Investing
Mon, February 27, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (CDXS) at Strong Buy with Decreased Target to $9 on, Feb 27th, 2023
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Codexis, Inc." (CDXS) at Strong Buy with Decreased Target from $15 to $9 on, Feb 27th, 2023.
Swayampakula has made no other calls on CDXS in the last 4 months.
There is 1 other peer that has a rating on CDXS. Out of the 1 peers that are also analyzing CDXS, 0 agree with Swayampakula's Rating of Hold.
This is the rating of the analyst that currently disagrees with Swayampakula
- Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $23 on, Thursday, January 19th, 2023
Contributing Sources